Mr. Jeff Courtney was appointed Chief Commercial Officer of the Fight Against Cancer Innovation Trust (FACIT), the commercialization partner for the Ontario Institute for Cancer Research (OICR) in November 2012. He is leading the Institute’s efforts to commercialize novel approaches to the diagnosis and treatment of cancer resulting from research conducted in Ontario. Mr. Courtney has extensive experience in venture capital, business development and strategic planning.
Prior to joining FACIT, Mr. Courtney was Managing Director of Verde Ventures, a management consulting firm specializing in providing financial and strategic advice to companies in the life sciences, health care and technology. As General Partner at VG Partners, Mr. Courtney was part of the leadership team that oversaw the $250M Advanced Life Sciences Fund. Mr. Courtney also was a partner at CDP Sofinov, President of Faulding Canada Inc., Executive Vice-President of Pharmascience Inc., and held various senior positions with Johnson & Johnson.
Mr. Courtney has served on numerous boards of directors for public and private enterprises in the biomedical industry and is currently a director on the boards of Turnstone Biologics Inc., XLV Diagnostics, Fusion Pharmaceuticals, Fluorinov Pharmaceuticals, Centre for Imaging Technology Commercialization (CIMTEC) and Centre for the Commercialization of Antibodies and Biologics (CCAB).